KR840006825A - 세포라인의 제조방법 - Google Patents
세포라인의 제조방법 Download PDFInfo
- Publication number
- KR840006825A KR840006825A KR1019830006314A KR830006314A KR840006825A KR 840006825 A KR840006825 A KR 840006825A KR 1019830006314 A KR1019830006314 A KR 1019830006314A KR 830006314 A KR830006314 A KR 830006314A KR 840006825 A KR840006825 A KR 840006825A
- Authority
- KR
- South Korea
- Prior art keywords
- serum
- tpa
- cell line
- incubator
- cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (26)
- 혈청-의존성 인간세포라인의 배양물로부터 혈청함유 배양기를 제거하고 대신에 혈청이 없는 배양기를 대치하고, 착생되거나 착생되지 않은 세포에 혈청이 없는 배양기를 공급하고, 혈청-비의존성 세포라인이 될 때까지 세포를 성장하게 하고, 필요시 수득한 혈청-비의존성 세포라인으로부터 혈청-비의존성돌연변이 세포라인을 생성함을 특징으로 하고, 혈청-비의존성 인간세포라인 또는 이로부터 유도된 혈청-비의존성 돌연변이 세포라인을 제조하는 방법.
- 제1항에 있어서, 혈청이 없는 배양기가 조절된 배양기이고, 조절된 배양기를 더 이상 필요로 하지 않을 때까지, 세포를 성장하게 하는 방법.
- 제2항에 있어서, 혈청이 없는 조절된 배양기를, 동료혈청-의존성 세포배양물로부터 수득하는 방법.
- 제1항에 있어서, 배양기 부재하에 세포를 약 30%이상으로 성장하게 하는 방법.
- 제1항에 있어서, 비-착생된 세포를 함유하는 배양기를 분리하고, 배양기로부터 비-착생된 세포를 분리하고, 이를 새로운 혈청이 없는 배양기와 함께 착생된 세포에 다시 가하여, 혈청이 없는 배양기를 제조하는 방법.
- 제1항에 있어서, 혈청이 없는 배양기의 일부분을, 24내지 72시간 간격으로, 새로운 혈청이 없는 배양기로 대치시켜, 혈청이 없는 배양기를 제조하는 방법.
- 제1항 내지 제6항중의 어느 하나에 있어서, 혈청-의존성 세포라인이 인간흑색종 세포라인인 방법.
- 제1항 내지 제6항중의 어느 하나에 있어서, 혈청-의존성 세포란인이 TPA 및 / 또는 프로-TPA를 생성하는 세포라인인 방법.
- 제1항 내지 제6항중의 어느 하나에 있어서, 혈청-의존성 세포란인이 보우스 I 세포라인인 방법.
- 제1항에 있어서, TPA 및/또는 프로-TPA를 생성하는 혈청-비의존성 세포라인 또는 이로부터 유도된 돌연변이 세포라인을 제조하는 방법.
- 제1항에 있어서, 보우스II 세포라인 또는 이로부터 유도된 혈청-비의존성 돌연변이 세포라인을 제조하는 방법.
- 제1항에 있어서, 상응하는 혈청-비의존성 돌연변이 세포라인을 제조하기 위해 수득한 혈청-비의존성 세포라인을 돌연변이원으로 처리하거나 조사(照射)시키는 방법.
- TPA 및/또는 프로-TPA를 생성할 수 있는 혈청-비의존성 인간세포를, 혈청이 없는 배양기중에서 배양하고, 목적하는 단백질을 하베스트 유체로부터 분리하고, 필요시 수득한 TPA 및 프로-TPA의 혼합물을 개개성분으로 분리 또는 전환시킴을 특징으로 하여, TPA, 프로-TPA 또는 이들의 혼합물을 제조하는 방법.
- 제13항에 있어서, 혈청-비의존성 인간세포가 보우스II 세포 또는 이의 돌연변이청인 방법.
- 제13항에 있어서, 수득한 혼합물중에 존재하는 프로-TPA를 효소적으로 TPA로 전환시킴을 특징으로 하여, 프로-TPA가 없는 TPA를 제조하는 방법.
- 제13항에 있어서, 분리 및 정제공정동안 프로테아제 억제제가 포함되어 있고, TPA를 선택적으로 억제하는 억제제의 존재하에서 최종정제를 수행함을 특징으로 하여, TPA가 없는 프로-TPA를 제조하는 방법.
- 제13항에 있어서, 조직 플라스미노겐 활성인자(TPA)와 프로-조직 플라스미노겐 활성인자(프로-TPA)의 혼합물을 제조하는 방법.
- 제17항에 있어서, 90%가 전-효소(proenzyme)형태이고, 10%가 활성효소형태인 조직플라스미노겐 활성인자(TPA)의 혼합물을 제조하는 방법.
- 제15항에 있어서, 수득한 TPA와 프로-TPA의 혼합물을, 플라스민이나 프로-TPA를 동일한 효과를 가지는 효소로 처리하는 것을 특징으로 하는 방법.
- 제16항에 있어서, 프로테아제 억제제가 아프로티닌 및 염기성 판크레아틱 트립신 억제제중에는 선택되는 방법.
- 제16항 및 20항중의 어느 하나에 있어서, 디이소프로필풀루오로포스페이트 또는 니트로페닐구아니디노벤조에이트의 존재하에, 선택적인 어피니티시약을 함유하는 칼럼상에서 크로마토그라피하여, 최종정제를 수행하는 방법.
- 제13항에 있어서, 모노클로날 안티-TPA항체 칼럼상에서 크로마토그라피하여, 최종정제를 수행하는 방법.
- 제13항에 있어서, 세포를 착생배양하는 방법.
- 제13항에 있어서, 세포를 현탁액 배양으로서 배양하는 방법.
- 제13항에 있어서, 수득한 하베스트 유체를 원심분리한 후, 어피니티 크로마토그라피시키는 방법.
- 제13항에 있어서, 분리 및 정제공정동안, 세제가 포함되어 있는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA82/9576 | 1982-12-30 | ||
ZA829576 | 1982-12-30 | ||
ZA9576 | 1982-12-30 | ||
ZA4576 | 1983-06-22 | ||
ZA834576 | 1983-06-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR840006825A true KR840006825A (ko) | 1984-12-03 |
KR900008740B1 KR900008740B1 (ko) | 1990-11-29 |
Family
ID=27134272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019830006314A KR900008740B1 (ko) | 1982-12-30 | 1983-12-30 | 혈청-비의존성 사람 세포주 및 이의 돌연변이 세포주를 제조하는 방법 |
Country Status (17)
Country | Link |
---|---|
US (2) | US4798796A (ko) |
EP (1) | EP0113319B1 (ko) |
JP (3) | JPH0632607B2 (ko) |
KR (1) | KR900008740B1 (ko) |
AU (1) | AU579812B2 (ko) |
CA (1) | CA1267620A (ko) |
DE (1) | DE3382390D1 (ko) |
DK (1) | DK607083A (ko) |
ES (2) | ES8600389A1 (ko) |
FI (1) | FI81377C (ko) |
GR (1) | GR78779B (ko) |
HU (1) | HU197766B (ko) |
IL (1) | IL70573A (ko) |
NO (1) | NO169497C (ko) |
NZ (1) | NZ206699A (ko) |
PH (1) | PH26514A (ko) |
PT (1) | PT77897B (ko) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA831399B (en) * | 1982-03-05 | 1984-02-29 | Health Lab Service Board | New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them |
EP0112122B1 (en) * | 1982-12-14 | 1991-08-28 | South African Inventions Development Corporation | Plasminogen activator |
JP2648301B2 (ja) * | 1983-12-27 | 1997-08-27 | ジエネテイツクス・インスチチユ−ト・インコ−ポレ−テツド | 真核細胞の形質転換のための補助dnaを含むベクター |
US5079159A (en) * | 1983-12-27 | 1992-01-07 | Genetics Institute, Inc. | Method for making tissue plasminogen activator |
US4757005A (en) * | 1984-04-19 | 1988-07-12 | Miles Inc. | Method and cell line for obtaining plasminogen activators |
US4929444A (en) * | 1985-05-28 | 1990-05-29 | Burroughs Wellcome Co. | Low pH pharmaceutical formulation containing t-PA |
DE3531966A1 (de) * | 1985-09-07 | 1987-03-12 | Arnim Ulrich Christoph Von | Verfahren zur langzeit-zuechtung beliebiger endothelzellen, methode zu ihrer identifizierung und charakterisierung und ihre verwendung fuer diagnose und klaerung der aetiopatogenese von krankheitszustaenden |
US4889808A (en) * | 1985-10-01 | 1989-12-26 | American Home Products | Method of enchancing t-PA and SCU-PA production |
PT84991B (pt) * | 1986-06-06 | 1990-03-08 | Genentech Inc | Processo para a producao de actividador do plasminogenio biologicamente activo |
JPS63196268A (ja) * | 1987-02-10 | 1988-08-15 | Kanegafuchi Chem Ind Co Ltd | 無血清培地で継代増殖可能な形質転換細胞、その育種方法およびその細胞による蛋白質の生産方法 |
EP0368926A4 (en) * | 1987-07-16 | 1991-11-27 | Codon | Transfected cells containing plasmids having genes oriented in opposing directions and methods of obtaining the same |
JPS6427472A (en) * | 1987-07-21 | 1989-01-30 | Meiji Milk Prod Co Ltd | Production of human tissue plasminogen activator and cell strain using therein |
US5128449A (en) * | 1988-07-05 | 1992-07-07 | The University Of Tennessee Research Corporation | Polypeptide and a method for its production |
DE3829244A1 (de) * | 1988-08-29 | 1990-03-01 | Boehringer Mannheim Gmbh | Verfahren zur herstellung von einkettigem t-pa |
FR2657884B1 (fr) * | 1990-02-05 | 1994-09-02 | Tm Innovation | Procede pour la preparation du facteur viii humain et d'analogues du facteur viii. |
US5227297A (en) * | 1990-04-17 | 1993-07-13 | Smithkline Beecham Corporation | Affinity purification ligands |
US5141862A (en) * | 1990-04-17 | 1992-08-25 | Smithkline Beecham Corporation | Method of purifying tpa or plasminogen activator using a tripeptide of the formula: -X-Y-argininal wherein X and Y are selected from the group consisting of pro,phe,trp and tyr |
US5122469A (en) * | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
US5405772A (en) * | 1993-06-18 | 1995-04-11 | Amgen Inc. | Medium for long-term proliferation and development of cells |
USH1532H (en) * | 1993-11-03 | 1996-05-07 | Genetics Institute, Inc. | Adaption of mammalian cell lines to high cell densities |
US5753489A (en) * | 1994-11-10 | 1998-05-19 | Immuno Ag | Method for producing viruses and vaccines in serum-free culture |
US6146873A (en) * | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
US5698433A (en) * | 1994-11-10 | 1997-12-16 | Immuno Ag | Method for producing influenza virus and vaccine |
US5756341A (en) * | 1994-11-10 | 1998-05-26 | Immuno Ag | Method for controlling the infectivity of viruses |
US5849585A (en) * | 1995-05-10 | 1998-12-15 | Genetech, Inc. | Isolating and culturing Schwann cells |
US6033660A (en) * | 1995-05-10 | 2000-03-07 | Genentech, Inc. | Method of treating a nervous system injury with cultured schwann cells |
US5721139A (en) * | 1995-05-10 | 1998-02-24 | Genentech, Inc. | Isolating and culturing schwann cells |
US5714385A (en) * | 1995-05-10 | 1998-02-03 | Genentech, Inc. | Media for culturing schwann cells |
US6475725B1 (en) | 1997-06-20 | 2002-11-05 | Baxter Aktiengesellschaft | Recombinant cell clones having increased stability and methods of making and using the same |
WO2008099006A2 (en) * | 2007-02-16 | 2008-08-21 | Fondazione Centro San Raffaele Del Monte Tabor | Mitogen independence identifies a highly malignant population of tumor stem cells |
JP4891946B2 (ja) * | 2008-05-19 | 2012-03-07 | 大成ロテック株式会社 | 防水層の施工方法、アスファルトパネルの製造方法及びアスファルトパネル用型枠 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3904480A (en) * | 1972-10-24 | 1975-09-09 | Lilly Co Eli | Enhanced production of plasminogen activator |
NL8003402A (nl) * | 1980-06-11 | 1982-01-04 | Leuven Res & Dev Vzw | Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking. |
JPS5774085A (en) * | 1980-10-25 | 1982-05-10 | Ajinomoto Co Inc | Culture medium for cells originating from lymphocytes |
US4448879A (en) * | 1981-03-26 | 1984-05-15 | Hooper Trading Company | High yield process for in vitro production of serum-free and mitogen-free interleukin-2 |
US4517293A (en) * | 1981-03-26 | 1985-05-14 | Hooper Trading Co. N.V. | High yield process for in vitro production of serum-free and mitogen-free interleukin-2 using a roller bottle culture system |
US4544632A (en) * | 1981-06-12 | 1985-10-01 | Yuichi Yamamura | Human T cell lines and method of producing same |
EP0112122B1 (en) * | 1982-12-14 | 1991-08-28 | South African Inventions Development Corporation | Plasminogen activator |
JPS59169489A (ja) * | 1983-03-15 | 1984-09-25 | Otsuka Pharmaceut Co Ltd | ヒト培養株化細胞 |
EP0151579B1 (en) * | 1983-04-27 | 1995-09-06 | The President And Fellows Of Harvard College | Method and products for detection of human t cell leukemia virus |
-
1983
- 1983-12-22 NZ NZ206699A patent/NZ206699A/xx unknown
- 1983-12-23 DE DE8383810621T patent/DE3382390D1/de not_active Expired - Lifetime
- 1983-12-23 EP EP83810621A patent/EP0113319B1/en not_active Expired - Lifetime
- 1983-12-27 PT PT77897A patent/PT77897B/pt not_active IP Right Cessation
- 1983-12-28 GR GR73377A patent/GR78779B/el unknown
- 1983-12-28 FI FI834830A patent/FI81377C/fi not_active IP Right Cessation
- 1983-12-28 IL IL70573A patent/IL70573A/xx not_active IP Right Cessation
- 1983-12-28 CA CA000444308A patent/CA1267620A/en not_active Expired - Lifetime
- 1983-12-29 DK DK607083A patent/DK607083A/da unknown
- 1983-12-29 PH PH30049A patent/PH26514A/en unknown
- 1983-12-29 JP JP58252491A patent/JPH0632607B2/ja not_active Expired - Lifetime
- 1983-12-29 NO NO83834866A patent/NO169497C/no unknown
- 1983-12-29 HU HU834513A patent/HU197766B/hu not_active IP Right Cessation
- 1983-12-29 AU AU22963/83A patent/AU579812B2/en not_active Ceased
- 1983-12-30 ES ES528570A patent/ES8600389A1/es not_active Expired
- 1983-12-30 KR KR1019830006314A patent/KR900008740B1/ko not_active IP Right Cessation
-
1985
- 1985-05-28 ES ES543559A patent/ES8606396A1/es not_active Expired
-
1986
- 1986-04-17 US US06/854,729 patent/US4798796A/en not_active Expired - Lifetime
-
1988
- 1988-10-04 US US07/253,190 patent/US5147790A/en not_active Expired - Fee Related
-
1993
- 1993-08-02 JP JP5191357A patent/JP2534020B2/ja not_active Expired - Lifetime
-
1995
- 1995-12-13 JP JP7324299A patent/JPH08205859A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR840006825A (ko) | 세포라인의 제조방법 | |
US4190708A (en) | Production of urokinase | |
DE3855375D1 (de) | Proteolytische enzyme | |
EKFORS et al. | Four Isozymic Forms of a Peptidase Resembling Kallikrein. Purified from the Rat Submandibular Gland | |
Hashimoto et al. | Some properties of acid protease from the thermophilic fungus, Penicillium duponti K1014 | |
IE830480L (en) | Fibrinolytic enzymes | |
KR100249995B1 (ko) | 터모코쿠스 유래 열안정성 프로테아제 | |
Gilbert et al. | Characterization and partial purification of the plasminogen activator from human neuroblastoma cell line, SK-N-SH: A comparison with human urokinase | |
Lysenko | Pathogenicity of Bacillus cereus for insects: I. Production of phospholipase C | |
Teng et al. | Production of Factor X and Factor Xa variants with thrombin, acutin and by autolysis | |
Wang et al. | Milk-clotting activity of proteinases produced by Rhizopus | |
KR100189660B1 (ko) | 바실러스속 균주 유래의 혈전용해효소 | |
Barlow et al. | Biosynthesis of plasminogen activator by tissue culture technique | |
Laxer et al. | Further purification and characterization of a thermophilic rennet | |
Nerud et al. | Production of milk-clotting enzymes by basidiomycetes | |
ATE5199T1 (de) | Verfahren zur gewinnung von glucosedehydrogenase und hierfuer geeignete mikroorganismen. | |
Uyeda et al. | Purification and Properties of API–2b→ API–2c Converting Protease from Streptomyces griseoincarnatus Strain No. KTo–250, an API–2 Producer | |
DE3064409D1 (en) | Process for the production of cholesterol esterase | |
SU973615A1 (ru) | Способ получени тромболитических ферментов специфичных к фибрину | |
US3207674A (en) | Process of producing fibrinolytic material from cephalosporium | |
ES8302773A1 (es) | Procedimiento de obtencion de una renina microbial de alta actividad coagulante de leche y baja actividad proteolitica | |
SU973609A1 (ru) | Среда дл отбора продуцентов фибринолитических ферментов | |
SU1486517A1 (ru) | Способ получения карбоксипептидазы | |
JPS6123994B2 (ko) | ||
JPS62239990A (ja) | 新規リパーゼ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 19951103 Year of fee payment: 6 |
|
LAPS | Lapse due to unpaid annual fee |